Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical Ownership Summary

Takeda Pharmaceutical is owned by 0.58% institutional investors, 0.01% insiders, and 99.41% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.43% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical	0.58%	0.01%	99.41%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Specialty & Generic Drug Manufacturers Stocks	26.16%	11.89%	61.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	13.40M	0.43%	$196.24M
Morgan stanley	7.69M	0.25%	$112.59M
Ubs group	5.89M	0.19%	$86.29M
Goldman sachs group	4.95M	0.16%	$72.52M
Fmr	4.19M	0.13%	$61.30M
Brandes investment partners, lp	3.93M	0.13%	$57.56M
Renaissance	3.86M	0.12%	$56.58M
Blackrock funding, inc. /de	3.31M	0.11%	$48.42M
Toronto dominion bank	3.00M	0.10%	$43.98M
Blackrock	1.44M	0.09%	$18.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.49M	2.69%	$21.76M
Xy capital	200.03K	1.54%	$2.93M
Clean yield group	266.04K	1.10%	$3.89M
Abc arbitrage sa	571.86K	0.82%	$8.37M
Legacy wealth asset management	166.48K	0.59%	$2.44M
Gold investment management	103.88K	0.51%	$1.52M
Brandes investment partners, lp	3.93M	0.46%	$57.56M
Carrera capital advisors	150.60K	0.40%	$2.20M
Bridgefront capital	83.73K	0.36%	$1.23M
Corient ia	25.00K	0.27%	$366.00K

Top Buyers

Holder	Shares	% Assets	Change
Toronto dominion bank	3.00M	0.07%	3.00M
Ubs group	5.89M	0.01%	1.87M
Arrowstreet capital, limited partnership	2.83M	0.03%	1.61M
Qube research	1.78M	0.03%	1.43M
Abc arbitrage sa	571.86K	0.82%	571.86K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-2.53M
Millennium management	246.66K	0.00%	-1.75M
Soleus capital management	-	-	-1.18M
Bank of america corp /de/	867.06K	0.00%	-616.95K
Blackrock	1.44M	0.00%	-558.24K

New Positions

Holder	Shares	% Assets	Change	Value
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Voloridge investment management	82.21K	0.00%	82.21K	$1.20M
Highland capital management	61.65K	0.04%	61.65K	$902.56M
Caprock group	53.46K	0.02%	53.46K	$801.39K
Dynasty wealth management	48.22K	0.01%	48.22K	$705.94K

Sold Out

Holder	Change
Northwest financial advisors	-1.00
West branch capital	-3.00
Point72 asia (singapore) pte.	-3.00
High note wealth	-13.00
Ameritas investment partners	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	203	-33.88%	18,053,624	-72.33%	-	3.49%	110	-39.56%	45	-28.57%
Jun 30, 2025	309	-0.32%	77,823,025	9.47%	4	24.04%	185	9.47%	63	-29.21%
Mar 31, 2025	3	-98.99%	4,050,360	-94.38%	-	1.24%	2	-98.64%	1	-98.94%
Dec 31, 2024	182	-40.13%	33,476,783	-56.07%	2	9.19%	84	-48.47%	58	-31.76%
Sep 30, 2024	301	5.24%	76,190,360	5.65%	4	23.28%	160	33.33%	85	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Capital Group American Mutual Comp	12.89M	0.41%	-
American Funds American Mutual A	12.89M	0.41%	-
First Trust Value Line® Dividend ETF	2.61M	0.08%	661.00
VanEck Pharmaceutical ETF	1.19M	0.04%	8.50K
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
MAP Global Equity Composite	716.61K	0.02%	6.57K
Steward International Enhanced Index I	651.53K	0.02%	315.75K
Steward Values Enhanced International I	651.53K	0.02%	-
Capital Group American Mutual Trust U0	407.53K	0.01%	94.57K
MAP Global Balanced Composite	391.63K	0.01%	4.24K

Insider Transactions Trends

Date	Buy	Sell
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 0.58%, followed by 0.01% insiders and 99.41% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.4M shares, 0.43%), Morgan stanley (7.69M shares, 0.25%), and Ubs group (5.89M shares, 0.19%). Together, they hold 0.86% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

Yes, BlackRock owns 0.09% of Takeda Pharmaceutical, totaling 1.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 18.59M$. In the last quarter, BlackRock decreased its holdings by -558K shares, a -27.99% change.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.69% of its assets in 1.49M Takeda Pharmaceutical shares, valued at 21.76M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

Capital Group American Mutual Comp is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.41% of its total shares outstanding invested in 12.89M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools